Find out more about Dennis Carney's experience
Dennis Carney's highlights
FEATURED Journal article
Clonal hematopoiesis, myeloid disorders and BAX-mutated myelopoiesis in patients receiving venetoclax for CLL
Read moreDennis Carney's selected work
Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibit..
Journal article
Substantial Susceptibility of Chronic Lymphocytic Leukemia to BCL2 Inhibition: Results of ..
Journal article
Shielding the Vulnerable: A Multicentre Australian Rollout of Evusheld to Patients with Ch..
Conference Proceedings
[F-18]FDG-PET-CT compared with CT for persistent or recurrent neutropenic fever in high-ri..
Journal article
PF388 HAT-PCR IS MORE SENSITIVE THAN FLOW FOR QUANTIFYING MRD IN CHRONIC LYMPHOCYTIC LEUKE..
Journal article
AN UNDETECTABLE PB MRD STATUS SHOULD BE THE THERAPEUTIC GOAL WITH VENETOCLAX THERAPY IN RE..
Conference Proceedings
Dennis Carney's selected work
Scholarly Works
Displaying the 10 most recent scholarly works from 55 for Dennis Carney.
Honours, Awards and Fellowships
FRCPA - Fellow of the Royal College of Pathologists, Australia
FRACP - Fellow of the Royal Australasian College of Physicians
Credentials
Positions
Clinical Supervisor
Medical Education
Member
HSANZ
Member
Australasian Leukaemia and Lymphoma Group
Member
Victorian Intravenous Immunoglobulin Users Group
Education
Bachelor of Medicine, Bachelor of Science
Monash University
Certificates & Licences
Medical Board of Victoria, Australia
Awarded: 27 Sept 2006